Catecholamine storage in schizophrenia
Baru, A.M.; Mys'ko, G.N.
Voprosy Meditsinskoi Khimii 23(4): 550-554
1977
ISSN/ISBN: 0042-8809 PMID: 919379 Document Number: 113007
After administration of isadrine excretion of noradrenaline was increased in schizophrenic patients with symptoms of depression or anxiety. This phenomenon was not observed in healthy persons and in patients with circular depression. Data on liberation of noradrenaline by other amines in schizophrenia and displacement of noradrenaline in schizophrenia by isadrine, which does not accumulate in normal storage sites, suggest that storage of noradrenaline is impaired in schizophrenia.
Document emailed within 1 workday
Related Documents
Strobel, G.; Friedmann, B.; Jost, J.; Bärtsch, P. 1994: Plasma and platelet catecholamine and catecholamine sulfate response to various exercise tests American Journal of Physiology 267(4 Pt 1): E537-E543Fritzsche, I.; Buehrdel, P.; Melcher, R.; Hans-Joachim Boehme 2001: Stability of Ketone Bodies in Serum in Dependence on Storage Time and Storage Temperature Clinical Laboratory 42(7-8): 399-403
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Roxo, H. 1952: Pseudoneurotics; patients at the onset of schizophrenia; differential diagnosis of neurasthenia and schizophrenia; modern therapy Imprensa Medica 28(463): 25-30
Kotlicka-Antczak, M.; Rabe-Jabłońska, J. 1997: Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia Psychiatria Polska 31(5): 527-538
Tsirkin, S.Iu. 1987: International study of schizophrenia based on a WHO program. Incidence of schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1203-1207
Arraras, J.I.; Basterra, I.; Pereda, N.; Ibañez, B.; Iribarren, S.; Cabases, J.M. 2019: The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) questionnaire. A validation study with Spanish schizophrenia spectrum outpatients Actas Espanolas de Psiquiatria 47(3): 97-109
Nishiyama, M.; Hayashi, S.; Kabutomori, O.; Yamanishi, H.; Suehisa, E.; Kurata, Y.; Kashiwagi, H.; Tomiyama, Y. 2011: Effects of anticoagulants and storage temperature on immature platelet fraction % (IPF%) values in stored samples measured by the automated hematology analyzer, XE-5000--utility of CTAD-anticoagulation and room temperature storage Rinsho Byori. Japanese Journal of Clinical Pathology 59(5): 452-458
Suzuki, S. 1982: The mental maturation and verbal alteration in a mild case of chronic non-paranoiac schizophrenia. a linguistic-phenomenological approach to the concept of schizophrenia simplex Seishin Shinkeigaku Zasshi 84(1): 1-19
Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Williams, J.; Spurlock, G.; McGuffin, P.; Mallet, J.; Nöthen, M.M.; Gill, M.; Aschauer, H.; Nylander, P.O.; Macciardi, F.; Owen, M.J. 1996: Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group Lancet 347(9011): 1294-1296
Keefe, R.S.; Mohs, R.C.; Davidson, M.; Losonczy, M.F.; Silverman, J.M.; Lesser, J.C.; Horvath, T.B.; Davis, K.L. 1988: Kraepelinian schizophrenia: a subgroup of schizophrenia? Psychopharmacology Bulletin 24(1): 56-61
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Kawamura, T.; Kuroda, Y.; Saitoh, Y. 1992: Long-term preservation of canine pancreas by a new simple cold storage method using perfluorochemical--the two-layer cold storage method (Euro-Collins' solution/perfluorochemical) Kobe Journal of Medical Sciences 38(2): 135-145
Dadić-Hero, E.; Ruzić, K.; Palijan, T.Z.ć; Graovac, M.; Siuc-Valković, D.; Knez, R.; Grahovac, T. 2013: Relations between the course of illness, family history of schizophrenia and family functioning in persons with schizophrenia Collegium Antropologicum 37(1): 47-55
Nakayasu, N.; Seki, Y.; Harima, H. 1999: Age of onset, frequency of the development of symptoms, and treatment outcome in the early stage of schizophrenia--in search of guidelines for early diagnosis and treatment of schizophrenia Seishin Shinkeigaku Zasshi 101(11): 898-907
Özdemir, H.İb.; Eker, M.Ça.ğd.ş; Zengin, B.ça.; Yılmaz, D.çe.A.ın.; İşman Haznedaroğlu, D.; Çınar, C.; Kitiş, Öm.; Akay, A.; Gönül, A.S. 2012: Gray matter changes in patients with deficit schizophrenia and non-deficit schizophrenia Turk Psikiyatri Dergisi 23(4): 237-246
Hano, T.; Nishio, I. 2000: Catecholamine Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 1): 423-427
Tokunaga, H.; Tomita, K. 1999: Catecholamine Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 205-208